Log In
BCIQ
Print this Print this
 

ARC-LPA

  Manage Alerts
Collapse Summary General Information
Company Arrowhead Pharmaceuticals Inc.
DescriptionRNAi-based therapeutic
Molecular Target Lipoprotein(a) (LPA)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA
Latest Stage of DevelopmentPreclinical
Standard Indication Cardiovascular (unspecified)
Indication DetailsTreat cardiovascular disease
Regulatory Designation
PartnerAmgen Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$673.5M

$35.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

09/29/2016

$673.5M

$35.0M

Undisclosed

Get a free BioCentury trial today